SBC brings TechBio event to Shoreditch

Around 45 entrepreneurs and experts working within the fields of tech-bio and therapeutics came together for TechBio, an event hosted by Stevenage Bioscience Catalyst in Shoreditch this month.

The stimulating networking event featured a panel discussion to explore the intersection of biotech and data with representation from leading sector experts:

• Duncan Young, Head of Business Development at Redx Pharma, focussing on oncology and fibrosis;
• Ben Pellegrini, CEO and Co-Founder, Intellegens, which applies machine learning to accelerate innovation within manufacturing, materials and chemicals;
• Dr. Uday Phadke, CEO and Co-Founder, Triple Chasm, which provide tools, training and content underpinned by data to help start-ups scale up.

Delegates were treated to a lively debate followed by pizza and drinks with extra food donated to the Samaritans at Liverpool Street Station. 

The event was very positively received with excellent feedback on the speakers, quality of debate, importance of networking and sharing insights within the overlapping spheres of biotech and data. 

Marco Delise, PhD, Entrepreneurship & Business Development Director, Stevenage Bioscience Catalyst, said: “TechBio brought together expertise from across biotech and big data to help drive innovation and help tackle the challenges faced by fledging companies in translating ideas into commercial, social and environmental impact. 

“The importance of AI both to the biotech sector and the UK economy as a whole has been re-affirmed with the Government’s recent pledge to commit £100m to establish an AI taskforce.” 

The Catalyst organises the Catalyser programme together with Triple Chasm and Mindstream AI, to help start-ups in these fields refine their commercialization strategy. The programme is open to companies planning to create their first commercially viable product which either have or are planning to integrate digital and data technologies (i.e. ML/AI) in their R&D workflow.

The next Catalyser programme, which starts on 23 May at zero cost to attendees, has been heavily oversubscribed. A total of 15 businesses took part in the 2021 ‘data’ cohort including BigOmics Analytics; Biotix.ai; Enedra Therapeutics; Exogene; Glamorous AI; iLoF; Kantify and seven more.  

For more information on future programmes and events, contact Marco Delise.

ENDS